
Product Details
Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus. It lowers blood glucose by helping the kidneys remove excess glucose from the body through urine. In certain adults with heart failure, empagliflozin helps reduce the risk of cardiovascular death and hospitalization due to heart failure. It is also used in certain adults with chronic kidney disease to help reduce the risk of kidney disease progression, cardiovascular death, and hospitalization for heart failure. Available strengths include 10 mg and 25 mg tablets.